论文部分内容阅读
目的:分析经尿道等离子电切术(TUPKRP)治疗良性前列腺增生症(BPH)的临床疗效。方法:对采用经尿道等离子电切术(TUPKRP)治疗良性前列腺增生症(BPH)126例患者的临床资料进行回顾性分析。结果:手术时间平均41.6±26.5分钟,术中出血量平均72.4±2.8mL,无输血病例,无包膜穿孔、闭孔神经反射及经尿道电切综合征(TURS)发生。随访2～12个月,无术后附睾炎、无尿道狭窄、真性尿失禁发生,术后IPSS、QOL、Qmax和RUV指标均较术前明显改善(P<0.01)。结论:TUPKRP治疗BPH具有术野清晰,切割精确,术中出血少、并发症少、术后恢复快,是一种安全、疗效确切的理想手术方法,值得临床推广应用。
Objective: To analyze the clinical efficacy of transurethral resection of plasma (TUPKRP) in the treatment of benign prostatic hyperplasia (BPH). Methods: The clinical data of 126 patients with benign prostatic hyperplasia (BPH) treated with transurethral plasmakill (TUPKRP) were retrospectively analyzed. Results: The average operation time was 41.6 ± 26.5 minutes. The intraoperative blood loss was 72.4 ± 2.8 mL. There were no transfusion cases, no capsule perforation, obturator nerve reflex and transurethral resection syndrome (TURS). All cases were followed up for 2 to 12 months. No postoperative epididymitis, no urethral stricture and true urinary incontinence occurred. The indexes of IPSS, QOL, Qmax and RUV after operation were significantly improved (P <0.01). Conclusions: TUPKRP is a safe and effective surgical method that is suitable for clinical diagnosis and treatment of BPH. It has the advantages of clear surgical field, accurate cutting, less intraoperative bleeding, less complications and rapid postoperative recovery.